logo
logo
Sign in

Global Positive Allosteric Modulators Market to Grow by a Significant CAGR during 2022 – 2031

avatar
Henry Smith
Global Positive Allosteric Modulators Market to Grow by a Significant CAGR during 2022 – 2031

Research Nester published a report titled “Positive Allosteric Modulators Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global positive allosteric modulators market in terms of market segmentation by disease type, drug type, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global positive allosteric modulators market is anticipated to attain a significant CAGR over the forecast period, i.e., 2022 – 2031. The market is segmented on the basis of disease type into Parkinson’s disease, schizophrenia, Alzheimer’s disease, and others, out of which, the Alzheimer’s disease segment is anticipated to hold a substantial share over the forecast period on account of high prevalence of the disorder across the globe. As per the data by the World Health Organization (WHO), 55 million people live with dementia worldwide, as of 2020, out of which 60-70% cases are of Alzheimer’s disease.

The global positive allosteric modulators market is estimated to witness growth over the forecast period, owing to the increasing prevalence of mental disorders, such as, dementia, schizophrenia, and others. Positive allosteric modulators are used as a combination with already prescribed medicines for patients with Alzheimer’s and Parkinson’s disease. Moreover, allosteric modulators are also used for medical research and development of new drugs. As per the data by the World Bank research and development expenditure amounted to 2.203% of the GDP in 2018.

On the basis of geographical analysis, the global positive allosteric modulators market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period on account of the higher health awareness amongst the population, along with higher investment in the R&D activities in the region. As per the World Bank data, 2.734% of GDP of North America was spend for R&D activities in 2018.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Increasing Investment in Medical R&D Activities to boost the Market Growth

Allosteric modulators are extensively employed for the development of new drugs, by studying the impact of drugs on enzyme-catalyzed chemical reactions in the cells. Moreover, the growing expenditure of research activities by the government, as well as the private companies, is further estimated to promote the use of positive allosteric modulators. Such factors are expected to boost the market growth.

However, poor adoption of advanced technology in low-income regions, along with side effects associated with the drugs are expected to operate as key restraint to the growth of global positive allosteric modulators market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global positive allosteric modulators market which includes company profiling of Acadia Pharmaceuticals Inc., Eli Lilly and Company, Novartis AG, Bayer AG, Sanofi-aventis Groupe, Abbott Laboratories, Johnson & Johnson Services, Inc., Merck & Co., Inc., Siemens Healthcare GmbH, and Pfizer Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global positive allosteric modulators market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Request Report Sample@ https://www.researchnester.com/sample-request-3979

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: [email protected]

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

 


collect
0
avatar
Henry Smith
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more